Skip to main content
. 2023 Mar 10;44(6):417–426. doi: 10.1097/MNM.0000000000001684

Table 1.

Baseline patient characteristics (n = 226)

Age (years) 54 (45–67)
History of breast cancer 40 (18%)
Positive family history 53 (24%)
Referral by breast cancer screening program 90 (40%)
Hormonal status
 Premenopausal 63 (28%)
 Perimenopausal 26 (11%)
 Postmenopausal 131 (58%)
 Unknown 6 (3%)
Symptoms
 No symptoms 99 (44%)
 Pain 14 (6%)
 Palpable mass 60 (26%)
 Skin abnormality 11 (5%)
 Nipple discharge 42 (19%)
Clinical classification
 No abnormalities 114 (50%)
 Benign 55 (24%)
 Uncertain benign 36 (16%)
 Uncertain malignant 21 (9%)
Breast density
 a.Mostly fatty 37 (16%)
 b.Some density (scattered) 92 (41%)
 c.Moderately dense (heterogeneous) 81 (36%)
 d.Extremely dense 16 (7%)
Indication MBI
 BI-RADS 3 lesion 49 (22%)
 Discrepancy with clinical findings 44 (19%)
 History of breast surgery and equivocal lesion 24 (11%)
 Mammography-detected lesion, occult with ultrasound 63 (28%)
 MRI-detected lesion, occult with ultrasound 7 (3%)
 Nipple discharge and equivocal or negative mammography + ultrasound 39 (17%)

Data are median (IQR) or N (%).